ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro, Inc.

In a report released today, Frank Takkinen from Lake Street maintained a Buy rating on ClearPoint Neuro, with a price target of $30.00. According t...

Lake Street Remains a Buy on ClearPoint Neuro (CLPT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Delcath Systems (DCTH – Research Report) and ClearPo...

Market Cap	$381.73M	P/E Ratio	N/A
52W High	$30.10	52W Low	$9.76
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-0.5%	52W Position	14.5%
Overall Score	49	Value Score	40
Quality Score	71	Technical Score	36

EPS Current Est	$-0.85	EPS Next Est	$-0.75
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLPT	$12.71	-2.00%	607.00K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLPT	$12.71	-2.0%	607.00K
3
4
5
6

CLPT

CLPT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get ClearPoint Neuro, Inc. Data in Excel

Get ClearPoint Neuro, Inc. Data in Excel